Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4597714019 | Neomycin 5 mg/g cutaneous ointment | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
4597715018 | Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Is a | Product containing neomycin in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Topical neomycin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Skin anti-infective | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Neomycin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Local anti-infective | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Bactericide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | Conventional release cutaneous ointment | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator unit | microgram | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Is a | Product containing only neomycin in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has precise active ingredient | Neomycin | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator value | 5 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has basis of strength substance | Neomycin | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Neomycin 0.5% ointment - product | Is a | False | Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets